← Eichor
Study identifier: NCT05827042 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion

Condition: Basilar Artery Occlusion · Acute Cerebrovascular Accident · Stroke Due to Basilar Artery Occlusion  ·  Sponsor: The First Affiliated Hospital of University of Science and Technology of China

PhasePhase 3
Planned participants338
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

To assess the effect of endovascular thrombectomy alone compared to intravenous thrombolysis plus endovascular thrombectomy in acute basilar artery occlusion patients within 4.5 hours from onset on efficacy and safety outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Wei Hu, MD  ·  +8615155510611  ·  andinghu@ustc.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

The First Affiliated Hospital of University of Science and Technology of ChinaHefei, Anhui, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05827042